1. Home >
  2. M&A >
  3. Divestiture >
  4. Russia >
  5. Alvogen Acquires Bayer Pharma AG - Hormonal Branded Products

M&A Deal Summary

Alvogen Acquires Bayer Pharma AG - Hormonal Branded Products

On October 6, 2015, Alvogen acquired life science company Bayer Pharma AG - Hormonal Branded Products from Bayer

Acquisition Highlights
  • This is Alvogen’s 5th transaction in the Life Science sector.
  • This is Alvogen’s 1st transaction in Russia.

M&A Deal Summary
Date 2015-10-06
Target Bayer Pharma AG - Hormonal Branded Products
Sector Life Science
Buyer(s) Alvogen
Sellers(s) Bayer
Deal Type Divestiture

Target

Bayer Pharma AG - Hormonal Branded Products

Russia
Bayer Pharma AG - Hormonal Branded Products - Klimonorm (Hormone replacement therapy), Progynova (Hormone replacement therapy), Triquilar ( Female contraception) and Microgynon (Female contraception) and Climene (Hormone replacement therapy).

Search 205,705 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alvogen

Morristown, New Jersey, United States
Category Company
Founded 2009
Sector Life Science
Employees2,000
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology, and gastroenterology. Alvogen has commercial operations in over 30 countries across North America, Central and Eastern Europe, and the Asia Pacific. Alvogen was founded in 2009 and is based in Morristown, New Jersey.

DEAL STATS #
Overall 5 of 8
Sector (Life Science) 5 of 8
Type (Divestiture) 2 of 4
Country (Russia) 1 of 2
Year (2015) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-06 Dream Pharma

Seoul, South Korea

Dream Pharma Corp. is a generic pharmaceutical company.

Buy $187M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-03 County Line Pharmaceuticals

Brookfield, Wisconsin, United States

County Line Pharmaceuticals LLC is a specialty generic pharmaceutical company focusing on growth through the acquisition or in-licensing of under-appreciated generic assets, marketing of Authorized Generic products and the development of specialty generic products.

Buy -

Seller(S) 1

SELLER

Bayer

Leverkusen, Germany
Category Company
Founded 1863
Sector Life Science
Employees98,189
Revenue 47.6B EUR (2023)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 8 of 23
Sector (Life Science) 1 of 6
Type (Divestiture) 5 of 19
Country (Russia) 1 of 1
Year (2015) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-01 Covestro

Leverkusen, Germany

Covestro is a provider of high-value polymers and innovative solutions for key sectors such as transportation, construction, electronics, furniture, sports equipment and textiles. Covestro was founded in 1863 and is based in Leverkusen, Germany.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-15 proPlant Gesellschaft für Agrar- und Umweltinformatik mbH

Münster, Germany

proPlant Gesellschaft für Agrar- und Umweltinformatik mbH is a plant health diagnosis and infection level warning service provider.

Buy -
Mergr

Product

Company

Legal